Isomorphic Labs

Isomorphic Labs is a biotechnology company based in London, founded in 2021 as a subsidiary of Alphabet Inc. The company focuses on using advanced artificial intelligence to enhance drug discovery and development. It originated from DeepMind and utilizes the Nobel-winning AlphaFold technology to accurately predict protein structures, which helps identify new drug target pathways. The company has developed an AI-driven drug discovery platform that predicts protein folding and molecular interactions, enabling efficient in-silico screening of compound libraries. Isomorphic Labs also released AlphaFold 3, a highly accurate AI model for predicting biological molecule structures, available for non-commercial research. The company collaborates with major pharmaceutical firms like Novartis and Eli Lilly to apply its technology in drug research, aiming to accelerate the identification of potential treatments across various disease areas. With a strong focus on innovation, Isomorphic Labs is committed to transforming the drug design process through its AI capabilities.